Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Black Diamond Therapeutic Q1 Earnings

Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Black Diamond Therapeutic beat estimated earnings by 6.56%, reporting an EPS of $-0.57 versus an estimate of $-0.61.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 6.9% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Black Diamond Therapeutic visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Laboratory Instruments Company Waters Corp Projects Steady Growth Amid Global Sales Fluctuations: Details

By Anusuya Lahiri
May 7, 2:55 PM
Waters Corp (NYSE: WAT) reported Q1 2024 sales of $636.8 million, beating analyst consensus. Quarterly rev declined 7%. Adjusted EPS was $2.21, beating Wall Street estimate. Outlook: full-year org constant currency sales growth -0.5% to +1.5%, and Q2 org constant currency sales decline (6)% - (4)%. Stock gained 9% in last 12 months. WAT shares trading higher at $322.12.

WAT